Publications
2026
-
Marius J., Ziane-Chaouche L., Raffo-Romero A., Salzet M., Duhamel M., et al. TREM2 blockade reprograms HER2 CAR macrophages toward inflammatory phagocytes in breast cancer models. Cancer Immunology, Immunotherapy. DOI: 10.1007/s00262-026-04576-9.
-
Fine J., Trottein F., Machelart A. Unraveling the multifaceted impact of tuberculosis on coinfections. iScience, 29(8), 117133. DOI: 10.1016/j.isci.2026.117133.
-
Sencio V., Bouzet C., Fine J., Costa C., Grandé A., Vandeputte A., Van Maele L., Rouanet C., Sirard J.-C., Machelart A. BCG immunisation through intranasal instillation protects mice against Streptococcus pneumoniae infection by enhancing alveolar macrophage activity. Scientific Reports.
-
Martel M.-E., José-Garcia A., Vens C., De Vos M., Sobanski V. Artificial intelligence for precision medicine. Therapies, 81(2), 171–186. DOI: 10.1016/j.therap.2025.10.003.
-
Distler J. H. W., Launay D., Feghali-Bostwick C., Matei A.-E., Trojanowska M., Gudjonsson J. E. Mechanisms of fibrotic tissue remodelling: insights from systemic sclerosis. Nature Reviews Rheumatology, 22, 221–238. DOI: 10.1038/s41584-025-01349-z.
2025
-
Collet A., Guerrier T., Sanges S., Chepy A., Sobanski V., Launay D., Dubucquoi S. Autoreactive B cells in autoimmune diseases: Mechanisms, functions and clinical implications. Autoimmunity Reviews, 24(8), 103851. DOI: 10.1016/j.autrev.2025.103851.
-
Elhannani A., Martel M.-E., Collet A., Chepy A., Sanges S., Hachulla E., Dubucquoi S., Launay D., Sobanski V. Anti-RNA polymerase III antibodies in systemic sclerosis: prevalence and clinical associations from a systematic review and meta-analysis. Rheumatology, 64(12), 6023–6035. DOI: 10.1093/rheumatology/keaf392.
-
Pochet A., Brodin P., Gref R., Machelart A. Beta-cyclodextrins in infectious disease therapy: A review of their function beyond simple drug carriers. Carbohydrate Polymer Technologies and Applications, 11, 100921. DOI: 10.1016/j.carpta.2025.100921.
-
Bourguignon T., Godinez-Leon J. A., Pochet A., et al. Pulmonary delivery of clofoctol-loaded nanoparticles inhibits SARS-CoV-2 replication and reduces pneumonia. International Journal of Pharmaceutics, 677, 125634. DOI: 10.1016/j.ijpharm.2025.125634.
-
Chepy A., Vivier S., Bray F., et al. Immunoglobulins G from Patients with Systemic Sclerosis Modify the Molecular Signatures of Endothelial Cells. RMD Open, 11(1), e004290. DOI: 10.1136/rmdopen-2024-004290.
-
McGown A., Renault N., Barczyk A., et al. Characterization of the Active Enantiomer and Mapping of the Stereospecific Intermolecular Pattern of a Reference P2X7 Allosteric Antagonist. ACS Pharmacology & Translational Science, 8(2), 446–459. DOI: 10.1021/acsptsci.4c00582.
-
Chepy A., Collet A., Launay D., Dubucquoi S., Sobanski V. Autoantibodies in systemic sclerosis: From disease bystanders to pathogenic players. Journal of Translational Autoimmunity, 10, 100272. DOI: 10.1016/j.jtauto.2025.100272.
2024
-
Fougiaxis V., Barcherini V., Petrovic M. M., et al. First fragment-based screening identifies new chemotypes inhibiting ERAP1-metalloprotease. European Journal of Medicinal Chemistry, 280, 116926. DOI: 10.1016/j.ejmech.2024.116926.
-
Bentaleb C., Adrouche S., Finkelstein J., et al. HIV-1 inhibits IFITM3 expression to promote the infection of megakaryocytes. Journal of Molecular Cell Biology, 16(9), mjae042. DOI: 10.1093/jmcb/mjae042.